Skip to main contentBack to Top

The overall goals of the Molecular Oncology & Biomarkers program are to understand the fundamental cellular and molecular processes that contribute to cancer development and progression.

Normal cells have intricate molecular mechanisms that control essential phenotypes such as differentiation, cell division and movement. The molecular pathways that control these phenotypes are disrupted in cancer cells as a result of the expression of oncogenes and loss of regulatory tumor suppressor genes. These events, which are often highly specific to individual types of cancer, disrupt specific molecular pathways that result in uncontrolled cell growth and loss of normal responses to extracellular signaling cues that result in tumor development and progression.

The research interests of the program can be divided into three broad themes:

  • Cancer Genetics
  • Epigenetics
  • Chaperone Biology

Collectively these themes address important topics of tumor cell and molecular biology including

  • The genetic basis of cancer development and progression through the roles of specific genes and pathways
  • The genetic basis of metastasis underlying the roles of metastasis suppressor genes, metastasis promoting genes, and microRNAs involved in metastasis
  • The role of transcription factors in promoting cancer progression
  • Cancer genomics in primary human tumors and mouse models of cancer using gene expression and Next Gen sequencing;
  • Application of bioinformatics tools to study complex data sets;
  • The role of oncogenes and glycoconjugates in cancer cell progression;
  • Genome-wide analysis of epigenetic changes in cancer development as a tool to identify biomarkers for prediction of progression and prognosis;
  • Analysis of heat shock chaperones and other stress proteins in cancer development and as targets for cancer therapies;
  • The role of obesity and metabolic changes in the development of cancer.

Program Members

photo of Satyanarayana Ande, PhD

Satyanarayana Ande, PhD

  • Associate Professor
photo of Ahmed Chadli, PhD

Ahmed Chadli, PhD

  • Associate Professor
photo of Zheng Dong, PhD

Zheng Dong, PhD

  • Regent's Professor
photo of Quansheng Du, PhD

Quansheng Du, PhD

  • Associate Professor
photo of Hasan Korkaya, DVM, PhD

Hasan Korkaya, DVM, PhD

  • Assistant Professor
photo of Vivian Lui, Ph.D.

Vivian Lui, Ph.D.

  • Associate Professor
photo of Huidong Shi, PhD

Huidong Shi, PhD

  • Professor
photo of Chunhong Yan, PhD

Chunhong Yan, PhD

  • Associate Professor

Cancer Research News

A professor teaches a classroom of students

Georgia Cancer Center mobile lab gives high school students hands-on experience exploring cancer research

A mobile lab is rolling through high schools with the goal to educate and inspire the next generation of cancer researchers.

Man and woman standing in research lab

Georgia Cancer Center awarded $2.3 million grant for acute myeloid leukemia research to improve patient survival

A new $2.3 million grant from the National Cancer Institute is giving the Georgia Cancer Center the opportunity to understand how those cancer cells resist primary treatment and propose new treatment options that may improve patient survival.

Three people in white coats stand in lab looking at camera

Cancer that spreads to the lung maneuvers to avoid being attacked by “killer” T cells

The discovery may help explain why sometimes promising immunotherapies designed to help the immune system kill cancer don’t.

Man in white lab coat and glasses props hands on lab equipment

Disproportionate percentage of females with unexplained infertility have gene variants known to cause heart problems, cancer

The study is the first to identify increased prevalence of disease-causing genetic variants in females with unexplained infertility.